Search

Searching with a thematic focus on Intellectual Property Rights, Trade Policy

Showing 291-300 of 420 results

Pages

• Document

  Summary report on the Conference of the Commission on Intellectual Property Rights

  International Institute for Sustainable Development, Winnipeg, 2002

  The Conference on How Intellectual Property Rights Could Work Better for Developing Countries and Poor People took place from 21- 22 February 2002, at the Royal Society in London, UK.
• Document

  WTO ministerial declaration on the TRIPs agreement and public health: the issues at stake

  European Commission, Directorate General for Trade, 2001

  Note which sets out the Trade Directorate General's (DG III) position on the agreement on TRIPS and access to essential medecines agreed at the Doha WTO MinisterialThe paper is set out in a question and answer format which addressed the following:What is the major value of this Declaration?Why was it necessary to clarify the relationship between TRIPs and public health?What cla
• Document

  Accord Bangui (Bangui Agreement)

  Access to Essential Medicines Campaign, MSF, 1999

  Full text of the original 1977 Bangui Agreement which established the African Organization for Intellectual Property (OAPI) and the 1999 revisions which brought the agreement in line with TRIPS.(In French)
• Document

  New options for African countries regarding protection for new varieties of plants

  GRAIN, 2001

  Examines the international protection of new varieties of plants, and outlines the difficulties developing countries in general, and African countries in particular, might encounter in the course of implementing these Conventions.The issues are examined for: UPOV Convention (1978 and 1991 Acts) TRIPSplant variety protection recommendations and the Convention on Biological Dive
• Document

  Drug patents in French-speaking Africa

  Access to Essential Medicines Campaign, MSF, 2000

  This paper summarises the measures included in the original 1977 Bangui Agreement, which established the African Organization for Intellectual Property (OAPI) and regulates patents and IP in 15 west African states. It goes on to discuss the revised agreement which brought IP regulation in that region into line with the WTO TRIPS Agreement.
• Document

  Intellectual property and the knowledge gap

  Oxfam, 2001

  Policy paper for presentation to the world social forum 2002. Provides a basic introduction to issues relating to IPRs, bilateral regulation, the TRIPS agreement and the impact of these policies on developing countries.
• Document

  Intellectual property rights and development

  International Centre for Trade and Sustainable Development, 2001

  Preliminary draft that aims to encourage policy discussion on the impact of intellectual property rights on development with particular reference to the TRIPS agreement. The draft paper draws no conclusions but provides a comprehensive summary of issues with particular reference to developing countries.
• Document

  Booklet of CGIAR Centre policy instruments, guidelines and statements on genetic resources, biotechnology and intellectual property rights

  Bioversity International, 2001

  Collection of genetic resources biotechnology and IPR related policies produced by Future Harvest Centres and subsequently endorsed by CGIAR members, GRPC and / or the Centre Directors Committee for System-wide adoption.The first section of the booklet concerns the policies and guidelines for managing the in-trust plant genetic resources collections.
• Document

  What did Doha accomplish?

  International Intellectual Property Institute, 2001

  This short opinion piece from IIPI is critical of those 'activists' calling for abrogation of patent laws in cases of health crises and particulalrly of their claims of victory in securing the Doha declaration. The author argues that the degree of flexibility in the application of TRIPS remains unchanged by the declaration.
• Document

  Patent protection and access to HIV/AIDS pharmaceuticals in Sub-Saharan Africa

  World Intellectual Property Organization, 2000

  This paper reviews the TRIPS patent and, in particular, those provisions relevant to the issue of pharmaceuticals and the patent situation in sub-Saharan Africa with regard to the protection of anti-retroviral HIV/AIDS drugs. Patent offices and pharmaceutical companies were surveyed to discover the extent to which anti-retroviral HIV/AIDS drugs were being patented.

Pages